Qlaira® is the first oral therapy approved for the treatment of HMB with added contraceptive benefit.1*

Qlaira® provides significant and rapid reduction of HMB after the first cycle with sustained efficacy throughout the treatment period1*

Qlaira® reduces menstrual blood loss by 88% after six months of treatment1

*In women without organic pathology who require oral contraception